2009
DOI: 10.1016/j.ijcard.2008.06.034
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: A prospective randomized trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 40 publications
0
10
0
3
Order By: Relevance
“…37, 38 In addition to prophylactic antifibrillatory therapy for POAF, identification and control of the risk factors is expected to play an important role in decreasing the rate of new-onset POAF in at-risk cardiac patients. The present results shows that decreased eGFR is significantly associated with a higher rate of new-onset POAF, longer hospital stay and worse 30-day morbidity or mortality.…”
Section: Discussionmentioning
confidence: 99%
“…37, 38 In addition to prophylactic antifibrillatory therapy for POAF, identification and control of the risk factors is expected to play an important role in decreasing the rate of new-onset POAF in at-risk cardiac patients. The present results shows that decreased eGFR is significantly associated with a higher rate of new-onset POAF, longer hospital stay and worse 30-day morbidity or mortality.…”
Section: Discussionmentioning
confidence: 99%
“…También se ha reportado que el uso de drogas para la prevención de FA como el uso de betabloqueadores y amiodarona puede reducir la mortalidad a largo plazo en este grupo de pacientes 7,18,19,20 . Los trabajos a largo plazo han mostrado que un importante factor predisponente de mortalidad siguiendo a la cirugía coronaria es la FAPO.…”
Section: Resultsunclassified
“…El bisoprolol fue el BBCS más utilizado en tanto que el BB no cardioselectivo más usado fue el propranolol. Por lo tanto, nuestros hallazgos concuerdan con los de otros autores que reportan incidencias de FAPO entre 10 y 12% con bisoprolol comparado con 30 a 40% en sujetos que recibieron propranolol [18][19][20] . La limitación más importante del estudio es el relativamente bajo número de sujetos incluidos y, en especial, el menor poder estadístico para detectar diferencias signifi- cativas de mortalidad con solo 6 pacientes fallecidos.…”
Section: Discussionunclassified
“…12 Experimental studies have found that bisoprolol extends ERP of the atria and has a potential antiarrhythmic effect in the treatment of AF. [13][14][15] It is possible to co-administer bisoprolol with propafenone 16 , which due to its high effi ciency, is a drug of fi rst choice for treatment of atrial fi brillation [17][18][19][20] . Based in these fi ndings we can use bisoprolol as the drug for a selective beta-blockade in propafenone treatment.…”
Section: Discussionmentioning
confidence: 99%